.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Citi
Express Scripts
Novartis
Accenture
QuintilesIMS
Mallinckrodt
Harvard Business School
McKinsey
Chubb

Generated: November 19, 2017

DrugPatentWatch Database Preview

Medpointe Pharm Hlc Company Profile

« Back to Dashboard

What is the competitive landscape for MEDPOINTE PHARM HLC, and what generic and branded alternatives to MEDPOINTE PHARM HLC drugs are available?

MEDPOINTE PHARM HLC has twenty approved drugs.



Summary for Medpointe Pharm Hlc

US Patents:0
Tradenames:18
Ingredients:17
NDAs:20
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medpointe Pharm Hlc
MICRAININ
aspirin; meprobamate
TABLET;ORAL084978-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Medpointe Pharm Hlc
RONDOMYCIN
methacycline hydrochloride
CAPSULE;ORAL060641-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Medpointe Pharm Hlc
DIUTENSEN-R
methyclothiazide; reserpine
TABLET;ORAL012708-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Medpointe Pharm Hlc
AQUATENSEN
methyclothiazide
TABLET;ORAL017364-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Medpointe Pharm Hlc
BUTICAPS
butabarbital sodium
CAPSULE;ORAL085381-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Medpointe Pharm Hlc
WAMPOCAP
niacin
CAPSULE;ORAL011073-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Medpointe Pharm Hlc
MEPROSPAN
meprobamate
CAPSULE, EXTENDED RELEASE;ORAL011284-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Medpointe Pharm Hlc
MILPREM-400
estrogens, conjugated; meprobamate
TABLET;ORAL011045-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Medpointe Pharm Hlc
BEPADIN
bepridil hydrochloride
TABLET;ORAL019001-002Dec 28, 1990DISCNNoNo► Subscribe► Subscribe► Subscribe
Medpointe Pharm Hlc
UNITENSEN
cryptenamine tannates
TABLET;ORAL009217-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Medpointe Pharm Hlc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Medpointe Pharm Hlc
BEPADIN
bepridil hydrochloride
TABLET;ORAL019001-001Dec 28, 1990► Subscribe► Subscribe
Medpointe Pharm Hlc
BEPADIN
bepridil hydrochloride
TABLET;ORAL019001-003Dec 28, 1990► Subscribe► Subscribe
Medpointe Pharm Hlc
BEPADIN
bepridil hydrochloride
TABLET;ORAL019001-002Dec 28, 1990► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Moodys
QuintilesIMS
Cantor Fitzgerald
Julphar
Covington
McKesson
Fuji
Queensland Health
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot